Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Cure My Disease

Don't miss your cure!

 Log in / Sign up

COPD patients breathe easier with digital rehab in new study

NCT ID NCT06582082

Symptom relief Sponsor: Cairo University Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed This study
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 1 time

Summary

This study tested whether a 10-week digital pulmonary rehabilitation program, done at home via video calls and a smartphone app, could improve lung function, thinking skills, and sleep quality in people with chronic obstructive lung disease (COPD). Sixty stable COPD patients aged 55-65 took part. The study group received the digital rehab plus usual care, while the control group had usual care alone. Researchers measured breathing tests, cognitive tests, and sleep patterns to see if the digital approach helped.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

Active substance
telepulmonary rehabilitation
What this could lead to
If it works, this could offer a convenient home-based program to help COPD patients breathe better, think clearer, and sleep more soundly.
What could go wrong
This is a small, completed study with only 60 participants. The results may not apply to everyone with COPD, and digital rehab may not work as well as in-person programs.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Participants

60 people

The number who actually took part.

Started

Sep 2024

Finished

Feb 2026

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

50 to 60 years

Sex

Anyone

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * All gender COPD patients * Age will be 55-65 years. * • Medically stable * Exclusion Criteria: * Very severe COPD - Lung cancer * Lung resection - Lung fibrosis * Heart failure - Cognitive disorders that affect the device application * Musculoskeletal or neurological disorders that interfere with exercise program * requiring invasive or non-invasive positive pressure ventilation * inability to speak in complete sentences due to breathlessness * suspected elevated intracranial pressure - hemodynamic instability * recent facial, oral, or skull surgery * active hemoptysis (more than two tablespoons of frank blood per day) * pneumothorax - failure to comply with the research protocol. * uncontrolled hypertension, or other concomitant respiratory diseases * participate at any research or pulmonary rehabilitation program during the period of this study. * imaging changes of lung disease such as occupancy, exudation and interstitial changes on CT scan.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Chronic obstructive lung disease are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Conditions

The condition(s) this trial relates to.

chronic obstructive pulmonary disease

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Chronic obstructive lung disease

Contacts and locations

Locations

  • Faculty of Physical Therapy

    Cairo, Egypt

More trials for these conditions

Other studies related to the condition(s) this trial covers.